CASP3 and hepatocellular carcinoma: For instance, in hepatocellular carcinoma (HCC) cells, Romidepsin has been found to induce apoptosis and G2/M phase arrest through the activation of JNK/c-Jun/caspase-3 and Erk/cdc25C/cdc2/cyclinB pathways, respectively [48].